Alex Grigsby brings a decade of experience in clinical research, business, and behavioral neuroscience to our team. Through former experience as a Director of Development and project manager, she confidently develops and implements processes that ensure patient safety and clinician integrity at IPTB. Clinically, she has extensive knowledge within applied behavior analytics and spent several years providing therapy to patients with psychological disorders. Alex has successfully guided over 300 clinical research patients within phase I, II, III, and open label extension studies. At the center of Alex’s day-to-days, she is most concerned with propelling the future of medicine and seeks to provide ethical, conscientious, and consistent care to all patients at IPTB.

Jennifer Santiago, MA has been in the medical field for over 15 years with expertise in both clinical trials and behavioral health. Aside from her practical skills, Jennifer has a genuine and compassionate approach to patient care. She provides medical assistance in the Spravato clinic and works with subjects enrolled in clinical research studies. She is available to answer questions and schedule appointments daily Monday through Friday.
She can be reached at 813-251-1800 or at admin@interventionalpsychiatrytb.com

Elizabeth Moreno has worked in research for the past six years. She has successfully guided over 500 clinical research participants within psychiatric, adolescent, neurologic, vaccine, cardiologic, and endocrine trials. Elizabeth has experience in every phase of human research, ranging from phase 1 studies to phase 4. She has exceptional work ethic and exercises excellent compassion when working with patients.
She can be reached at 813-251-1800 or at em@interventionalpsychiatrytb.com

Katie is an undergraduate at the University of Florida with a background in Neuroscience, Psychology, and Computer Science. She is interested in studying the intersection of neuroscience and technology in order to develop new therapies and treatments to improve the quality of life for patients living with a variety of neurological and psychiatric disorders. Previously, she ran experiments in a biomedical engineering research facility, worked in a psychology laboratory, and was involved in prostate cancer research. Katie enjoys the process of scientific discovery, especially when it is applied to improving healthcare. Working at IPTB, Katie is excited to connect patients with innovative new clinical research studies. 
 
She can be reached at 813-251-1800 or at research@interventionalpsychiatrytb.com

Drs. Kenneth Pages and Winderbaum Fernandez have been seamlessly co-managing the care of treatment resistant depression and mood disorder patients for over 10 years. At IPTB, Dr. Pages serves as a sub-investigator on multiple clinical trials focusing on Major Depressive Disorder. In affiliation with TMS of South Tampa we are able to offer patients the full complement of state of the art interventional psychiatric therapies. As one of the most experienced TMS doctors in the country, Dr. Pages was not only one of the first to provide TMS Therapy in Florida but he has devoted his practice to advancing the technology. He is a nationally recognized TMS provider and is actively involved in pushing the boundaries of how TMS can assist patients in their recovery and achieving remission. Our novel protocols such as combined esketamine/TMS therapy for treatment resistant depression have resulted in full recovery with sustained benefits and enabled patients to minimize oral medication use or avoid more burdensome treatment options.

Learn more about TMS of South Tampa at: 
www.tmsofsouthtampa.com

Dr. Philpot received a B.A. in Psychology, a M.A. in Experimental Psychology, and a Ph.D. in Cognitive and Neural Sciences at the University of South Florida. Dr. Philpot has been a professor and researcher in the field of neuroscience for more than 15 years. Currently, he is an assistant professor at USF’s College of Medicine Psychiatry and Behavioral Neurosciences division. His expertise focuses on neural processes, experimental design, descriptive and inferential statistics, research ethics, neurobiology, neurochemistry, and pharmacology.

Faizi Ahmed, MD is an Affiliate Assistant Professor of Psychiatry and Behavioral Neurosciences at the University of South Florida. He is board-certified in Psychiatry through the American Board of Psychiatry and Neurology and also board-certified in Neuropsychiatry and Behavioral Neurology through the United Council for Neurologic Subspecialties. Dr. Ahmed attended Temple University for his undergraduate studies. He earned his medical degree from Xavier University School of Medicine and then returned to Philadelphia where he completed his residency training at Temple University Hospital in psychiatry. After residency he spent one year treating patients with severe mental illness in an Assertive Community Treatment program in Swarthmore, PA. Dr. Ahmed then joined Johns Hopkins School of Medicine where he completed fellowship in Neuropsychiatry and Behavioral Neurology. He moved to Tampa in 2016 to start his private Neuropsychiatry practice, Tampa Neuropsychiatry LLC which has multiple locations throughout the Tampa Bay area. At IPTB, he serves as a sub-investigator on multiple clinical trials including those focusing on Major Depressive Disorder and Schizophrenia.